All-new research in dermatology is available now – take a look at this month’s new and exclusive content on JDDonline.com:
- In a multicenter clinical study, investigators conduct an analysis of data on the Effect of Calcipotriene/Betamethasone Dipropionate 0.005%/0.064% Foam on Target Lesions in Plaque Psoriasis: A Post-Hoc Analysis
-
Authors evaluate Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia in a retrospective chart review of TA patients treated with ILK at an academic dermatology clinic.
-
Real-World Clinical Experience With the IL-17 Receptor A Antagonist Brodalumab highlights the safety and efficacy and unique mechanisms of action of the IL-17 inhibitors.
-
Real-World Clinical Experience With the IL-17 Receptor A Antagonist Brodalumab highlights the safety and efficacy and unique mechanisms of action of the IL-17 inhibitors.
- The IL-17 pathway plays a crucial role in the immunopathogenesis and development of psoriasis in Clinical and Molecular Effects of Interleukin-17 Pathway Blockade in Psoriasis.
-
A Survey of Dermatologists’ Preparedness for Natural and Manmade Disasters examines whether the dermatology field has advanced in its bioterrorism preparedness since a 2003 survey revealed 88% of dermatologists felt unprepared to respond to a biological attack.
View all February JDD content, including editor’s picks, supplements, CME activities, case reports, and more!
Read Now
You May Also Like
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment
From the Vault: Expert Recommendations on Microbiome Balance, Secondary Infections, and Therapeutic Gaps Managing atopic dermatitis (AD) involves navigating a complex interplay between skin barrier dysfunction and microbial dysbiosis. As…
Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
Investigating Clascoterone Cream 1% for Papulopustular Rosacea: Key Takeaways This is a must-read article from JDD for clinicians seeking fresh therapeutic avenues for chronic facial dermatoses. Managing papulopustular rosacea often…
Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus
Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus
From the Vault: Managing Recurrent Hyperpigmentation Beyond Standard Hydroquinone Regimens Given its complex pathogenesis, chronicity, and high rates of recurrence, melasma remains one of the most challenging conditions in aesthetic…
